Analysts' Actions: APA CAG CHS DAL FITB

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Apache ( APA) was upgraded at Oppenheimer to outperform from perform. $100 price target. Stock has priced in risks and the company is buying back shares and debt, Oppenheimer said.

BB&T ( BBT) was upgraded at Goldman Sachs to buy. Stock appears inexpensive relative to its peers, Goldman said.

ConAgra ( CAG) was downgraded at J.P. Morgan to neutral from overweight. $33 price target. Consensus estimates have downside risk, J.P. Morgan said.

Cavium ( CAVM) was downgraded at Lazard Capital Markets to neutral from buy. Valuation call, as the stock has a price-to-earnings ratio of 29, based on expected 2014 earnings.

Church & Dwight ( CHD) was upgraded at Deutsche Bank to buy from hold. $66 price target. Company can sustain 3%-4% organic sales and double-digit earnings growth, annually, Deutsche Bank said.

Chico's FAS ( CHS) was upgraded at Keybanc to buy from hold. $21 price target. Company has long-term growth potential with earnings power approaching $2 a share, Keybanc said.

Comerica ( CMA) was upgraded at Goldman Sachs to neutral. Company should benefit from lower interest in short-end demand, Goldman said.

Charles River ( CRL) was initiated with a neutral rating at UBS. Reflects valuation, although there are early-stage signs of improvement, said UBS. Price target is $49.

Covance ( CVD) was initiated with a buy rating at UBS. Reflects its late-stage clinical development and margin-expansion opportunity, UBS said. Price target is $96.

Delta Air Lines ( DAL) was upgraded at J.P. Morgan to overweight from neutral. $26 price target. Newly introduced tax rate not to be confused with a diminished earnings outlook, J.P. Morgan said.

Fifth Third ( FITB) was downgraded at Goldman Sachs to neutral from buy. Company is leveraged to slower mortgage activity, Goldman said.

Fortuna Silver Mines ( FSM) was upgraded to hold at TheStreet Ratings.

Hologic ( HOLX) was downgraded to hold at TheStreet Ratings.

Kellogg ( K) was downgraded at J.P. Morgan to underweight from neutral. $60 price target. Top line concerns and difficult comparisons, J.P. Morgan said.

Kennametal ( KMT) was downgraded at Bank of America/Merrill Lynch. Valuation call, based on a $50 price target, BofA/Merrill said.

US Airways Group ( LCC) was upgraded at J.P. Morgan to overweight from neutral. $26 price target. Stand-alone prospects are materially better than implied by the market, J.P. Morgan said.

Mead Johnson Nutrition ( MJN) was upgraded at J.P. Morgan to overweight from neutral. $88 price target. Top-line growth should be valuedmore highly than the pending cost headwinds and the possibility of further Chinese government intervention, J.P. Morgan said.

Public Service Enterprise ( PEG) was upgraded at Jefferies to buy from hold. The company is gaining more political support for its "energy strong" capital spending program, said Jefferies. Price target is $37.

Quintiles ( Q) was initiated with a buy rating at UBS. Reflects scale, late-stage development exposure and supplemental growth from CSO, said UBS. Price target is $51.

Steve Madden ( SHOO) was downgraded at Wedbush to neutral from outperform. Valuation call, based on a $55 price target, Wedbush said.

Volcano ( VOLC) was upgraded at BMO Capital to outperform from market perform. $28 price target. Stock is attractively valued, and the company can achieve near-term earnings expectations, BMO Capital said.

Werner ( WERN) was downgraded at Keybanc to hold from buy. Company warned and is facing several issues, Keybanc said.

STOCK COMMENTS / EPS CHANGES

Aetna ( AET) numbers were raised at UBS. Estimates were raised as medical-claims trends should continue and CVH synergies could be better than expected, said UBS. Price target goes to $76.

Celldex ( CLDX) price target was raised at Jefferies to $29 ahead of CDX-1127 PI trial data release.

Packaging Corp of America ( PKG) numbers were reduced at Jefferies. Earnings estimates were adjusted lower to reflect less accretion from BZ acquisition, said Jefferies. Price target was reduced to $68.

PerkinElmer ( PKI) numbers were raised at UBS. Estimates were raised as the company enters expanding markets and balances investment vs. growth, said UBS. Price target goes to $43.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

The Stock Market Has Every Reason to See a Fresh Rally

The Stock Market Has Every Reason to See a Fresh Rally

3 Simple Tips on Investing From TheStreet's Jim Cramer

3 Simple Tips on Investing From TheStreet's Jim Cramer

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Tesla's Supercharger Network Is Booming -- Here's Why That's a Concern

Tesla's Supercharger Network Is Booming -- Here's Why That's a Concern

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly